Bio-Techne Advances Spatial Biology with Innovative COMET™ Platform
Today, Bio-Techne Corporation (NASDAQ: TECH) has made significant strides by releasing clinically relevant spatial biology data. This data originates from Bio-Techne's established Lunaphore platform, which comprises an array of instruments and kits designed to provide valuable solutions tailored for the translational research community.
Integration of COMET into Clinical Research Workflows
The COMET platform stands out as a premier spatial biology solution, designed to seamlessly fit into existing clinical research workflows. By employing clinically validated antibodies, researchers can rapidly develop and validate new panels. Moreover, COMET offers high-plex workflow automation, enhancing the value of clinical studies by enabling prompt and robust decision-making in treatment strategies.
Collaboration and Groundbreaking Findings
Recent research collaboration with prominent figures such as Professor Paolo Ascierto from the National Tumor Institute and the pioneering AI-driven company Nucleai revealed notable tumor microenvironment (TME) features that may predict responses to therapy. In a comprehensive study involving immunotherapy-treated metastatic melanoma patients, a sophisticated spatial immuno-oncology multiplex immunofluorescence (mIF) panel was merged with advanced AI analytics for the first time. The results underscore the potential of automated workflows and AI tissue analysis to broadly enhance immunotherapy drug development, ultimately aiming to improve patient outcomes.
Expert Insights on COMET
Dr. Ascierto commented, "COMET allows for the identification of various biomarkers and spatial interactions among different cell types within the TME. The collaboration with Nucleai's AI platform in predicting therapy responses signifies a remarkable leap in the application of this innovative technology during clinical trials. This is pivotal in recognizing predictive biomarkers."
Dr. Matt McManus, President of Bio-Techne's Diagnostics & Spatial Biology Segment, emphasized, "This study reflects our shared ambition to fast-track predictive spatial biomarker enhancements, showcasing how the COMET platform can facilitate more effective immunotherapy strategies in tackling advanced cancer cases, particularly metastatic melanoma. Our dedication to enhancing spatial biology within clinical research profoundly aims to transform patient outcomes."
Amplification Techniques Enhancing Clinical Research
In another notable study led by Professor Janis Taube from Johns Hopkins University School of Medicine, remarkable potential was demonstrated through novel amplification techniques available on the COMET platform. This advancement allows thorough profiling of the TME, paving the path for enhanced insights within clinical research.
Highlighting Innovations at Scientific Gatherings
At the Society for Immunotherapy of Cancer's Annual Meeting, new data sets will be presented that emphasize the scientific progress driven by the COMET platform. These showcases reflect the continued innovation and commitment to advancing treatment modalities through state-of-the-art research processes.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) stands as a leading global life sciences firm, offering innovative tools and bioactive reagents essential for research endeavors and clinical diagnostics. The company plays a vital role in assisting scientific exploration into biological mechanisms and disease progression. Its extensive product portfolio has been instrumental in drug discovery and accurate clinical testing. With an impressive revenue stream that reached approximately $1.2 billion in net sales recently and a workforce of about 3,100 employees globally, Bio-Techne continues to make a significant impact on the life sciences field.
About Lunaphore
Lunaphore Technologies S.A., a Bio-Techne brand founded in 2014, aims to democratize spatial biology across laboratories. Their cutting-edge chip technology facilitates the extraction of spatial proteomic and transcriptomic data from various tissues, transforming standard assays into multiplex formats effectively. This approach empowers researchers in fields such as immunology and neuroscience, significantly advancing scientific insight and the development of treatment strategies. Lunaphore's technology enables the identification of biomarker signatures that hold clinical relevance essential for refining diagnostic tools and streamlining clinical trials, ultimately contributing to improved patient health outcomes.
About COMET™
COMET™ is a fully automated, high-throughput platform designed to maintain scalability and reproducibility without necessitating the conjugation of primary antibodies. The platform features walk-away automation that integrates staining, imaging, and preprocessing steps, allowing for the collection of standardized hyperplex images. COMET™ excels in its multiomics capabilities, permitting the simultaneous profiling of both RNA and protein data within the spatial context of tissue samples. This functionality enhances researchers' understanding of cellular behaviors and disease developments, producing robust, reproducible data with preserved tissue integrity. COMET™ can analyze 40 different spatial markers per automated run. Its compatibility with standard histology glass slides and diverse biological samples—including human, mouse, and other animal tissues—positions it as a versatile tool across various research applications.
Frequently Asked Questions
What is the COMET platform?
The COMET platform is an advanced spatial biology solution developed by Bio-Techne that integrates automation and versatile analysis of biological samples.
How does COMET improve clinical research?
COMET enhances clinical research by automating workflows, allowing faster identification of biomarkers, and providing insights that improve patient treatment strategies.
Who collaborated with Bio-Techne in the recent studies?
Collaborators included doctors and researchers from renowned institutions, such as Prof. Paolo Ascierto and Nucleai, focusing on the tumor microenvironment and therapy response.
What are the key features of the COMET technology?
Key features include automated high-throughput capabilities, multiomics analysis, and the ability to work with standard laboratory samples, offering flexibility and efficiency.
Why is spatial biology significant in research?
Spatial biology provides insights into cellular interactions and functions in their native environments, crucial for understanding disease mechanisms and therapeutic responses.
